Bioventus director granted 25,146 RSUs, exercises 32,282

Bioventus Inc. director Pat Beyer reported equity compensation activity and an option-like vesting event.

Rhea-AI Filing Summary

Bioventus Inc. director Pat Beyer reported equity compensation activity and an option-like vesting event. On June 3, 2026, Beyer received a grant of 25,146 restricted stock units, each representing a contingent right to one share of Class A common stock. These RSUs will vest on the earlier of the day immediately preceding the issuer's first annual meeting of stockholders following the grant date or the first anniversary of the grant, subject to continued board service.

On June 2, 2026, previously granted RSUs vested and were exercised into 32,282 shares of Class A common stock, eliminating that RSU balance. Following these transactions, Beyer holds 108,718 shares of Class A common stock directly and 25,146 RSUs that remain outstanding.

Insider Trade Summary

32,282 shares exercised/converted

Exercise 3 txns

Insider Beyer Pat

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	25,146	$0.00	$0.00
Exercise	Restricted Stock Units	32,282	$0.00	$0.00
Exercise	Class A Common Stock	32,282	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 25,146 contracts (Direct); Class A Common Stock — 108,718 shares (Direct)

Footnotes (3)

1. F1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
2. F2. The RSUs vested on June 2, 2026.
3. F3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Key Figures

New RSU grant: 25,146 RSUs RSUs exercised: 32,282 RSUs Shares received from RSUs: 32,282 shares +2 more

5 metrics

New RSU grant 25,146 RSUs Grant to director Pat Beyer on June 3, 2026

RSUs exercised 32,282 RSUs Vested and converted on June 2, 2026

Shares received from RSUs 32,282 shares Class A common stock from RSU vesting

Shares held after transactions 108,718 shares Class A common stock directly owned by Pat Beyer

RSUs outstanding after grant 25,146 RSUs Unvested RSUs remaining after transactions

Key Terms

Restricted Stock Units, Class A Common Stock, Grant, award, or other acquisition, Exercise or conversion of derivative security, +1 more

5 terms

Restricted Stock Units financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Class A Common Stock financial

"Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock."

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

Exercise or conversion of derivative security financial

"transaction_code_description: Exercise or conversion of derivative security"

vest financial

"The RSUs vested on June 2, 2026."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Bioventus (BVS) director Pat Beyer report?

Pat Beyer reported equity awards and exercises. A new grant of 25,146 restricted stock units was received, and 32,282 previously granted RSUs vested and were exercised into 32,282 shares of Class A common stock, increasing direct share ownership.

How many Bioventus (BVS) restricted stock units did Pat Beyer receive?

Pat Beyer received 25,146 restricted stock units. Each RSU represents a contingent right to receive one share of Class A common stock. The units vest based on service on the Bioventus board and specific time-based conditions tied to the grant date.

When do Pat Beyer’s new Bioventus (BVS) RSUs vest?

The new RSUs vest on the earlier of the day immediately preceding the first annual meeting of stockholders following the grant date or the first anniversary of the grant, provided Pat Beyer continues serving on the Bioventus board through the applicable vesting date.

How many Bioventus (BVS) shares does Pat Beyer own after these transactions?

After the reported transactions, Pat Beyer directly owns 108,718 shares of Bioventus Class A common stock. In addition, 25,146 restricted stock units remain outstanding, representing a potential equal number of future shares upon vesting and settlement.

What happened to the previously granted Bioventus (BVS) RSUs for Pat Beyer?

Previously granted RSUs totaling 32,282 units vested on June 2, 2026. Those RSUs were exercised or converted into 32,282 shares of Bioventus Class A common stock, leaving no remaining balance for that specific RSU award after the transaction.

Does the Bioventus (BVS) Form 4 show any share sales by Pat Beyer?

The Form 4 shows no open-market share sales. The reported transactions are a new grant of 25,146 RSUs and the vesting and conversion of 32,282 RSUs into the same number of Class A common shares, increasing direct equity holdings.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 04:45 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Beyer Pat

(Last) (First) (Middle)

4721 EMPEROR BOULEVARD, SUITE 100

(Street)

DURHAM NORTH CAROLINA 27703

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Bioventus Inc. [ BVS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	06/02/2026		M		32,282	A	$0	108,718	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	06/02/2026		M			32,282	(2)	(2)	Class A Common Stock	32,282	$0	0	D
Restricted Stock Units	(1)	06/03/2026		A		25,146		(3)	(3)	Class A Common Stock	25,146	$0	25,146	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.

2. The RSUs vested on June 2, 2026.

3. The RSUs shall vest and become exercisable on the earlier of (i) the day immediately preceding the date of the Issuer's first Annual Meeting of Stockholders following the date of grant and (ii) the first anniversary of the date of grant, subject to the Reporting Person continuing in service on the Issuer's Board of Directors through the applicable vesting date.

Remarks:

	/s/ Anthony D'Adamio, Attorney-in-Fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)